| In vitro model of mesenchymal condensation during chondrogenic development S Ghosh, M Laha, S Mondal, S Sengupta, DL Kaplan Biomaterials 30 (33), 6530-6540, 2009 | 115 | 2009 |
| Quantifying osteogenic cell degradation of silk biomaterials S Sengupta, SH Park, GE Seok, A Patel, K Numata, CL Lu, DL Kaplan Biomacromolecules 11 (12), 3592-3599, 2010 | 57 | 2010 |
| Regulation of the JMJD3 (KDM6B) histone demethylase in glioblastoma stem cells by STAT3 MM Sherry-Lynes, S Sengupta, S Kulkarni, BH Cochran PloS one 12 (4), e0174775, 2017 | 48 | 2017 |
| Hypoxia and amino acid supplementation synergistically promote the osteogenesis of human mesenchymal stem cells on silk protein scaffolds S Sengupta, SH Park, A Patel, J Carn, K Lee, DL Kaplan Tissue engineering Part A 16 (12), 3623-3634, 2010 | 39 | 2010 |
| Characterization of natural, decellularized and reseeded porcine tooth bud matrices SB Traphagen, N Fourligas, JF Xylas, S Sengupta, DL Kaplan, ... Biomaterials 33 (21), 5287-5296, 2012 | 37 | 2012 |
| A large-scale RNAi screen identifies SGK1 as a key survival kinase for GBM stem cells S Kulkarni, S Goel-Bhattacharya, S Sengupta, BH Cochran Molecular Cancer Research 16 (1), 103-114, 2018 | 24 | 2018 |
| Engineered Cas12i2 is a versatile high-efficiency platform for therapeutic genome editing C McGaw, AJ Garrity, GZ Munoz, JR Haswell, S Sengupta, ... Nature communications 13 (1), 2833, 2022 | 20 | 2022 |
| Abstract C201: activity of the GlaxoSmithKline kinase inhibitor set on glioblastoma stem cells S Khagi, S Sengupta, T Tabtieng, BH Cochran Molecular Cancer Therapeutics 14 (12_Supplement_2), C201-C201, 2015 | 2 | 2015 |
| Gene editing systems comprising an RNA guide targeting lactate dehydrogenase a (LDHA) and uses thereof QN Wessells, JR Haswell, TM Ditommaso, NM Jakimo, S Sengupta US Patent 11,939,607, 2024 | | 2024 |
| Gene editing systems comprising an RNA guide targeting hydroxyacid oxidase 1 (HAO1) and uses thereof QN Wessells, JR Haswell, TM Ditommaso, NM Jakimo, S Sengupta US Patent 11,821,012, 2023 | | 2023 |
| Gene editing systems comprising an rna guide targeting hydroxyacid oxidase 1 (hao1) and uses thereof QN Wessells, JR Haswell, TM Ditommaso, NM Jakimo, S Sengupta US Patent App. 17/832,038, 2023 | | 2023 |
| Gene editing systems comprising an rna guide targeting lactate dehydrogenase a (ldha) and uses thereof QN Wessells, JR Haswell, TM Ditommaso, NM Jakimo, S Sengupta US Patent App. 17/832,114, 2023 | | 2023 |
| Gene editing systems comprising an rna guide targeting transthyretin (ttr) and uses thereof QN Wessells, JR Haswell, TM Ditommaso, NM Jakimo, S Sengupta US Patent App. 17/831,852, 2022 | | 2022 |
| Efficient Immune Cell Editing with Engineered CRISPR-Cas12i for Ex Vivo Cell Therapy S Sengupta, JR Haswell, E Keston-Smith, Q Wessells, AJ Garrity, P Yan, ... MOLECULAR THERAPY 30 (4), 450-450, 2022 | | 2022 |
| Detailed analysis of immune responses induced against patient-specific neoantigens using the ex-vivo induction protocol, NEO-STIM™ D Lenkala, J Kohler, B McCarthy, M Nelson, R DeBarge, Y Ware, ... Cancer Research 79 (13_Supplement), 580-580, 2019 | | 2019 |
| AN RNAi KINOME SCREEN IDENTIFIES THE YES1 KINASE AS A POTENTIAL TARGET FOR GLIOBLASTOMA S Goel-Bhattacharya, S Sengupta, B Cochran NEURO-ONCOLOGY 18, 46-46, 2016 | | 2016 |
| Function of STAT3 and SMG1 in maintaining Glioblastoma stem cells S Sengupta Tufts University-Graduate School of Biomedical Sciences, 2016 | | 2016 |
| Abstract C160: An RNAi kinome screen identifies YES1 as a potential target for glioblastoma S Goel-Bhattacharya, S Sengupta, BH Cochran Molecular Cancer Therapeutics 14 (12_Supplement_2), C160-C160, 2015 | | 2015 |
| Abstract A2-65: Integrating computational and experimental approaches to build predictive models of the SMG1 kinase network in glioblastoma stem cells S Sengupta, SK Young, S Goel-Bhattacharya, BH Cochran Cancer Research 75 (22_Supplement_1), A2-65-A2-65, 2015 | | 2015 |
| CSIG-03INTEGRATING COMPUTATIONAL AND EXPERIMENTAL APPROACHES TO UNDERSTAND THE SMG1 KINASE NETWORK IN GLIOBLASTOMA STEM CELLS S Sengupta, SK Young, S Goel-Bhattacharya, BH Cochran Neuro-oncology 17 (Suppl 5), v66, 2015 | | 2015 |
